Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/30/2009WO2009114874A3 Benzothiazole kinase inhibitors and methods of use
12/30/2009WO2009114459A3 Anti-neoplastic combination therapy comprising co-disruption pathway and mre11/rad50/nbs1 complex and compositon thereof
12/30/2009WO2009114201A3 Steroidal ligands and their use in gene switch modulation
12/30/2009WO2009114181A3 Substituted heterocycle fused gamma-carbolines solid
12/30/2009WO2009113033A3 Linear and cyclic guanidine derivatives, method of preparation and uses thereof
12/30/2009WO2009112678A3 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
12/30/2009WO2009111633A3 Mercaptan and seleno-mercaptan compounds and methods of using them
12/30/2009WO2009111439A3 In vivo detection of phospholipase activation
12/30/2009WO2009111354A3 Tyrosine kinase inhibitors
12/30/2009WO2009111277A9 Imidazo [4. 5-b] pyridine derivatives used as raf inhibitors
12/30/2009WO2009110955A3 Ketoconazole-derivative antagonists of human pregnane x receptor and uses thereof
12/30/2009WO2009109866A3 Intermediates and a process employing the intermediates for the preparation of (3-trifluoromethylsulfonyl)-n-[4-methyl-3- (4-pyridin-3-yl-pyrimidin-2ylamino)-phenyl]-benzamide
12/30/2009WO2009108785A3 Method for treating schizophrenia
12/30/2009WO2009108722A3 Substituted benzoxazinones
12/30/2009WO2009106748A3 Derivatives of n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
12/30/2009WO2009106708A3 Azetidine derivatives, their preparation and their application in therapy
12/30/2009WO2009105457A3 Slit2 cancer markers
12/30/2009WO2009105260A3 Ultra-small rnas as toll-like receptor-3 antagonists
12/30/2009WO2009102997A3 Acetyl mimic compounds for the inhibition of isoprenyl-s-cysteinyl methyltransferase
12/30/2009WO2009101021A3 Estradiol-containing drug delivery system
12/30/2009WO2009100342A3 Disease markers and uses thereof
12/30/2009WO2009100333A3 Sweetener compositions and methods of making them
12/30/2009WO2009099853A3 Angiotensin ii receptor antagonists
12/30/2009WO2009099405A3 Antibacterial compositions and methods of treatment
12/30/2009WO2009097259A3 Use of ibogamine congeners for treating obesity
12/30/2009WO2009097014A3 Therapeutic kinase modulators
12/30/2009WO2009090670A3 Stabilized sustained release composition of bupropion hydrochloride and process for preparing the same
12/30/2009WO2009089277A3 Rel inhibitors and methods of use thereof
12/30/2009WO2009089119A3 Decoy influenza therapies
12/30/2009WO2009088414A3 Oral pharmaceutical dosage forms
12/30/2009WO2009086303A3 Method for altering the lifespan of eukaryotic organisms
12/30/2009WO2009085978A8 Bridged carbocyclic oxime hepatitis c virus serine protease inhibitors
12/30/2009WO2009084036A3 Composition for treatment of viral infections
12/30/2009WO2009080808A3 Pharmaceutical for the treatment of fibrosing pulmonary diseases
12/30/2009WO2009077736A3 A medicament comprising a parasympathetic agonist and a sympathetic antagonist or a sympathetic agonist
12/30/2009WO2009076166A3 Oximyl hcv serine protease inhibitors
12/30/2009WO2009073643A3 Nitric oxide release coatings incorporating nitric oxide synthase enzyme
12/30/2009WO2009070753A3 Bivalent single chain fv antibody compositions that specifically bind to integrin receptor on a metastatic cell in a mammalian subject
12/30/2009WO2009067349A3 Modulation of the immune response
12/30/2009WO2009067245A3 Compositions and methods for tissue repair
12/30/2009WO2009065910A3 Acid addition salts of imatinib and formulations comprising the same
12/30/2009WO2009064920A3 Compounds and methods for modulating protein expression
12/30/2009WO2009062118A3 Modulation of protein trafficking
12/30/2009WO2009058818A3 Compositions comprising a micro-rna and methods of their use in regulating cardiac remodeling
12/30/2009WO2009044244A3 Production of monatin enantiomers
12/30/2009WO2009038842A3 Methods and compositions to inhibit edema factor and adenylyl cyclase
12/30/2009WO2009036340A3 Mpzp: a small molecule corticotropin-releasing factor type 1 receptor (crf1) antagonist
12/30/2009WO2009034541A9 Controlled release pharmaceutical dosage forms of trimetazidine
12/30/2009WO2009020877A3 Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof
12/30/2009WO2009020814A3 Fused heterocycles
12/30/2009WO2009019598A3 Inhalation therapy for respiratory disorders
12/30/2009WO2009017767A3 Compositions and methods for dermally treating neuropathy with minoxidil
12/30/2009WO2009009156A3 Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages
12/30/2009WO2009002922A3 Single dose roxithromycin
12/30/2009WO2009002802A3 Liquiritigenin and derivatives as selective estrogen receptor beta agonists
12/30/2009WO2009002425A3 Solubilized formulation of docetaxel without tween 80
12/30/2009WO2008157791A3 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones
12/30/2009WO2008157787A3 Hydroxylated tolans and related compounds in the treatment of cancer
12/30/2009WO2008157563A3 Deuterium-enriched clopidogrel
12/30/2009WO2008157562A3 Deuterium-enriched olanzapine
12/30/2009WO2008155588A8 Sulfonyl-quinoline derivatives
12/30/2009WO2008153902A3 Urotensin ii receptor antagonists
12/30/2009WO2008147482A3 Methods and compositions for improving immune responses
12/30/2009WO2008140335A3 Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
12/30/2009WO2008138327A9 Polymerase inhibitors and the use thereof for the treatment of tumors
12/30/2009WO2008134518A3 Methods and compounds for vitamin d therapy
12/30/2009WO2008121768A3 Glycan-binding proteins as therapeutic targets for retinal disorders and treatment methods based thereon
12/30/2009WO2008118754A3 Gamma radiation sterilized nanoparticulate docetaxel compositions and methods for making the same
12/30/2009WO2008118319A3 Mineralocorticoid receptor modulators
12/30/2009WO2008110928A3 Dual bandwidth time difference of arrival (tdoa) system
12/30/2009WO2008103415A3 Methods of preparing phosphoric acids of combretastatin and derivatives thereof
12/30/2009WO2008096369A3 Pharmaceutical formulation for use in hiv therapy
12/30/2009WO2008090517A3 Enriched plant extract, compound, and methods for the treatment of proliferative disorders
12/30/2009WO2008089034A3 Cytokine inhibitors
12/30/2009WO2008088852A3 Method of using squalene monooxygenase inhibitors to treat acne
12/30/2009WO2008087650A3 Composition and method for treating or preventing skeletal muscle fibrosis
12/30/2009EP2138575A1 Conjugates comprising a biodegradable polymer and uses therefor
12/30/2009EP2138498A1 Substituted tricyclic derivatives against neurodegenerative diseases
12/30/2009EP2138497A1 Novel adenine compound
12/30/2009EP2138496A1 Antitumoral analogs of lamellarins
12/30/2009EP2138495A1 Substituted pyrimido[2,1-a]isoquinolin-4-one derivatives
12/30/2009EP2138494A1 Substituted alkyl pyrimidin-4-one derivatives
12/30/2009EP2138493A1 Substituted pyrimidone derivatives
12/30/2009EP2138492A1 Substituted pyrimidin-4-one derivatives
12/30/2009EP2138489A1 Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same
12/30/2009EP2138488A1 4-(pyridin-4-yl)-1H-[1,3,5]triazin-2-one derivatives as GSK3-beta inhibitors for the treatment of neurodegenerative diseases
12/30/2009EP2138487A1 Substituted morpholine and thiomorpholine derivatives for the treatment of bipolar disorders
12/30/2009EP2138485A1 Substituted N-Oxide pyrazine derivatives
12/30/2009EP2138484A1 Fused bicyclic heteroaryl derivatives
12/30/2009EP2138482A1 Bicyclic heterocyclic compound
12/30/2009EP2138191A1 Enhanced transport using membrane disruptive agents
12/30/2009EP2138190A2 Compositions comprising dietary fat complexer and methods for their use
12/30/2009EP2138188A1 Combinations comprising antimuscarinic agents and beta-adrenergic agonists
12/30/2009EP2138179A1 Use of cytidine derivatives for the treatment of leukaemia
12/30/2009EP2138178A1 Oxazolidninones for the treatment fo chronic obstructive pulmonary disease (COPD) and/or asthma
12/30/2009EP2138177A1 Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments
12/30/2009EP2138176A1 Method of treating cognitive impairment
12/30/2009EP2138175A2 Formulations comprising valsartan for treating diabetes or microalbuminuria
12/30/2009EP2138174A1 Pharmaceutical composition in the form of a sublingual tablet consisting of a non-steroidal anti-inflammatory agent and an opiate analgesic for pain management
12/30/2009EP2138173A1 Pharmaceutical compositions comprising aminoadamantane derivatives
1 ... 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 ... 7860